[1]沈瑛锴,王新陆,王栋先,等.国医大师王新陆基于“血浊”运用“耦合援药”治疗2型糖尿病经验[J].陕西中医,2025,46(9):1253-1256.[doi:DOI:10.3969/j.issn.1000-7369.2025.09.020]
　SHEN Yingkai,WANG Xinlu,WANG Dongxian,et al.National traditional Chinese medicine master WANG Xinlu’s experience in treating type 2 diabetes with“Coupled aid drugs”based on “Blood turbidity”[J].,2025,46(9):1253-1256.[doi:DOI:10.3969/j.issn.1000-7369.2025.09.020]
点击复制

国医大师王新陆基于“血浊”运用“耦合援药”治疗2型糖尿病经验

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年9期
页码:
1253-1256
栏目:
名中医经验
出版日期:
2025-09-05

文章信息/Info

Title:
National traditional Chinese medicine master WANG Xinlu’s experience in treating type 2 diabetes with“Coupled aid drugs”based on “Blood turbidity”
作者:
沈瑛锴1; 王新陆1; 王栋先1; 朱文浩2; 赵帅3; 叶全1
（1.山东中医药大学，山东 济南 250014；2.淄博市中医医院，山东 淄博 255300；3.山东中医药大学第二附属医院，山东 济南 255001）
Author(s):
SHEN Yingkai1; WANG Xinlu1; WANG Dongxian1; ZHU Wenhao2; ZHAO Shuai3; YE Quan1
(1.Shandong University of Traditional Chinese Medicine,Jinan 250014，China;2.Zibo Traditional Chinese Medicine Hospital,Zibo 255300，China;3.The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250001，China)
关键词:
国医大师; 王新陆; 2型糖尿病; 血浊; 援药; 名医经验
Keywords:
National traditional Chinese medicine master; WANG Xinlu; Type 2 diabetes; Blood turbidity; Aid drug; Famous doctor experience
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7369.2025.09.020
文献标志码:
A
摘要:
国医大师王新陆教授基于“血浊”运用“耦合援药”治疗2型糖尿病（T2DM）的临证经验丰富。王新陆教授认为T2DM的特点为血失清纯，糖浊客脉；病发幽隐，须辨其征；虚浊相干，轩轾为害。治疗上常以化浊为基本方法，佐以补津、益气、理血、调肝、复脾、养元等法，运用耦合援药进行治疗。同时针对病之兼变，审因论治。在血浊理论指导下运用有降糖作用的耦合援药，贯通了中西壁垒，为临床辨治T2DM提供了新策略。
Abstract:
Professor WANG Xinlu,a master of Chinese medicine,has rich clinical experience in treating type 2 diabetes (T2DM) with “Coupled aid drugs” based on “Blood turbidity”.Professor WANG Xinlu believes that the characteristics of T2DM are impure blood,and the turbidity produced by blood sugar remains in the bloodstream;The onset process is not obvious and its symptoms need to be detected in advance;The combined effect of deficiency syndrome and turbid qi can harm the human body.In treatment,the basic method is often to remove turbidity,supplemented by methods such as tonifying the body,nourishing qi,regulating blood,regulating the liver,restoring the spleen,and nourishing the essence.Coupled Aid Drugs are used for treatment.At the same time,in response to the concurrent changes of the disease,the cause should be analyzed and treated accordingly.Guided by the theory of blood turbidity,the use of “Coupled aid drugs” with hypoglycemic effects has bridged the barriers between Chinese and western medicine,providing a new strategy for the clinical differentiation and treatment of T2DM.

参考文献/References:

[1]王新陆.“浊”与“血浊”[J].天津中医药,2019,36(9):833-838.
[2]KIM A R,JEONG S M,KANG M J,et al.Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus[J].Nutr Res Pract，2013,7(3):166-171.
[3]Gheitasi I,Savari F,Akbari G,et al.Molecular mechanisms of hawthorn extracts in multiple organs disorders in underlying of diabetes:A review[J].Int J Endocrinol，2022,2022:2002768.
[4]GO H K,RAHMAN M M,KIM G B,et al.Antidiabetic effects of yam (dioscorea batatas) and its active constituent,allantoin,in a rat model of streptozotocin-induced diabetes[J].Nutrients，2015,7(10):8532-8544.
[5]韩思婕,潘翔,朱芊芊,等.茯苓多糖调节2型糖尿病模型大鼠肝脏糖异生的机制研究[J].中国药房,2022,33(13):1581-1587.
[6]张宁,李自辉,于卉,等.玄参及其各组分的降血糖作用[J].中药药理与临床,2016,32(5):55-60.
[7]詹志敏,付万进,胡伟.基于网络药理学方法研究知母治疗2型糖尿病作用机制[J].安徽医药,2023,27(8):1525-1530，1701-1702.
[8]苏龙嘎.玫瑰花降糖成分的提取分离及其药理作用研究[D].呼和浩特：内蒙古医科大学,2021.
[9]侯朝军.月季花总黄酮对大、小鼠糖尿病模型的影响[D].郑州：河南中医学院,2015.
[10]GUO J,TAO H,CAO Y,et al.Prevention of obesity and type 2 diabetes with aged citrus peel (chenpi) extract[J].J Agric Food Chem，2016,64(10):2053-2061.
[11]杨静帆,李敏艳,秦燕勤,等.川陈皮素的药理活性研究进展[J].中医学报,2023,38(4):719-725.
[12]张成明,刘莹莹,郭亚男,等.中医脾脏本源探析[J].陕西中医,2022,43(2):227-230.
[13]邹洁,张德德,陶毅,等.葛根素对糖尿病KKAy小鼠氧化应激损伤的干预机制[J].陕西中医,2022,43(3):283-286.
[14]马倩.苍术多糖对T2DM患者肠道微生物的调节作用及代谢分析[D].天津：天津科技大学,2024.
[15]吴娇,仝芳超.黄芪的化学成分、药理作用及临床应用[J].滨州医学院学报,2024,47(1):68-75.
[16]王静,蒋杰,李新朋,等.天花粉治疗糖尿病物质基础及作用机制研究进展[J].药学研究,2021,40(10):684-686，697.
[17]王宏杨,迟继铭,姜雪,等.何首乌提取物二苯乙烯苷药理及临床研究进展[J].中华中医药学刊,2019,37(10):2464-2469.
[18]梁春晓,王珊珊,陈淑静,等.虎杖化学成分及药理活性研究进展[J].中草药,2022,53(4):1264-1276.
[19]吴冰,王轩.基于Notch信号通路探讨枸杞多糖对糖尿病肾病大鼠肾纤维化的改善作用[J].陕西医学杂志,2023,52(3):267-272.
[20]丁凡,王拥军,张岩.丹参活性成分的药理作用和临床应用研究进展[J].中华中医药杂志,2021,36(2):659-662.
[21]AN L,WANG Y,WANG C,et al.Protective effect of Schisandrae chinensis oil on pancreatic β-cells in diabetic rats[J].Endocrine，2015,48(3):818-825.
[22]卢军,芦霜.柏子仁研究进展[J].辽宁中医药大学学报,2013,15(3):247-250.
[23]ZHONG Y,LUO R,LIU Q,et al.Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress,apoptosis,and enhancing autophagy[J].Food Chem Toxicol，2022,159:112697.
[24]GUMBAREWICZ E,JARZB A,STEPULAK A,et al.Zingiber officinale rosc.in the treatment of metabolic syndrome disorders-A review of in vivo studies[J].Int J Mol Sci，2022,23(24):15545.
[25]LU Q,TANG Y,LUO S,et al.Coptisine,the characteristic constituent from coptis chinensis,exhibits significant therapeutic potential in treating cancers,metabolic and inflammatory diseases[J].Am J Chin Med,2023，51(8):2121-2156.
[26]YAGI T,ATAKA K,CHENG K C,et al.Red rice koji extract alleviates hyperglycemia by increasing glucose uptake and glucose transporter type 4 levels in skeletal muscle in two diabetic mouse models[J].Food Nutr Res，2020：64.
[27]HU J L,NIE S P,LI C,et al.In vitro effects of a novel polysaccharide from the seeds of Plantago asiatica L.on intestinal function[J].Int J Biol Macromol，2013，54:264-269.
[28]操兰洁,诸夔妞,蒋翠花,等.泽泻提取物对STZ糖尿病大鼠的干预作用[J].中国药科大学学报,2017,48(5):601-608.

相似文献/References:

[1]莫嘉浩,黄演芬,许洪彬,等.国医大师治疗郁证用药规律研究*[J].陕西中医,2020,(12):1830.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.040]
[2]张 岩,胡荣魁,谈 勇.国医大师夏桂成教授运用人工培育鹿科动物药治疗妇科疾病经验[J].陕西中医,2024,(1):100.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.023]
　ZHANG Yan,HU Rongkui,TAN Yong.Chinese medicine master professor XIA Guicheng's experience in treating gynecological diseases with deer family medicine[J].,2024,(9):100.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.023]

备注/Memo

备注/Memo:
国家重点研发计划项目（2023YFC3606203，2018YFC1704103）；国家中医药管理局第四届国医大师王新陆传承工作室建设项目（国中医药办人教函[2022]245号）
更新日期/Last Update: 2025-09-08